BioFactors,
Journal Year:
2023,
Volume and Issue:
49(6), P. 1174 - 1188
Published: June 22, 2023
Human
T
lymphotropic
virus
type
1
(HTLV-1)
infection
can
cause
adult
T-cell
lymphoblastic
leukemia
(ATLL),
an
incurable,
chemotherapy-resistant
malignancy.
In
a
quest
for
new
therapeutic
targets,
our
study
sought
to
determine
the
levels
of
AKT,
mTOR,
and
PI3K
in
ATLL
MT-2
cells,
HTLV-1
infected
NIH/3T3
cells
(Inf-3T3),
patients
(Carrier,
HAM/TSP,
ATLL).
Furthermore,
effects
rigosertib,
wortmannin,
rapamycin
on
PI3K/Akt/mTOR
pathway
inhibit
proliferation
were
examined.
The
results
showed
that
mRNA
expression
Akt/PI3K/mTOR
was
down-regulated
carrier,
patients,
as
well
MT-2,
Inf-3T3
compared
healthy
individuals
untreated
controls.
However,
western
blotting
revealed
increase
phosphorylated
activated
forms
AKT
mTOR.
Treating
with
rapamycin,
rigosertib
decreased
Akt
mTOR
restored
their
levels.
Using
these
inhibitors
also
significantly
boosted
pro-apoptotic
genes,
Bax/Bcl-2
ratio
tumor
suppressor
gene
p53
Inf-3T3cells.
Rigosertib
more
potent
than
wortmannin
inducing
sub-G1
G2-M
cell
cycle
arrest,
late
apoptosis
cells.
It
synergized
cytotoxic
vincristine.
These
findings
demonstrate
downregulation
level
may
occur
negative
feedback
response
increased
PI3K-Akt-mTOR
phosphorylation
by
HTLV-1.
Therefore,
using
alone
or
combination
common
chemotherapy
drugs
be
beneficial
patients.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Feb. 13, 2023
Introduction
The
Human
T-lymphotropic
virus
type
1
(HTLV-1)
was
the
first
described
human
retrovirus.
It
is
currently
estimated
that
around
5
to
10
million
people
worldwide
are
infected
with
this
virus.
Despite
its
high
prevalence,
there
still
no
preventive
vaccine
against
HTLV-1
infection.
known
development
and
large-scale
immunization
play
an
important
role
in
global
public
health.
To
understand
advances
field
we
performed
a
systematic
review
regarding
current
progress
of
Methods
This
followed
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-analyses
(PRISMA®)
guidelines
registered
at
International
Prospective
Register
(PROSPERO).
search
articles
PubMed,
Lilacs,
Embase
SciELO
databases.
From
2,485
identified,
25
were
selected
according
inclusion
exclusion
criteria.
Results
analysis
these
indicated
potential
designs
available,
although
paucity
studies
clinical
trial
phase.
Discussion
Although
discovered
almost
40
years
ago,
it
remains
great
challenge
neglected
threat.
scarcity
funding
contributes
decisively
inconclusiveness
development.
data
summarized
here
intends
highlight
necessity
improve
knowledge
retrovirus,
encouraging
more
on
aiming
eliminate
registration
https://www.crd.york.ac.uk/prospero
,
identifier
(CRD42021270412).
Virulence,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: April 29, 2025
Epstein-Barr
Virus
(EBV),
Kaposi's
sarcoma-associated
herpesvirus
(KSHV),
and
human
T-cell
leukemia
virus
type
1
(HTLV-1)
are
key
infectious
agents
linked
to
the
development
of
various
hematological
malignancies,
including
Hodgkin's
lymphoma,
non-Hodgkin's
adult
leukemia/lymphoma.
This
review
highlights
critical
knowledge
gaps
in
understanding
role
ferroptosis,
a
novel
form
cell
death,
virus-related
tumors.
We
focus
on
how
ferroptosis
influences
host
response
these
viral
infections,
revealing
groundbreaking
mechanisms
by
which
three
viruses
differentially
regulate
core
pathways
such
as
iron
homeostasis,
lipid
peroxidation,
antioxidant
systems,
thereby
promoting
malignant
transformation
cells.
Additionally,
we
explore
potential
antiviral
drugs
modulators
treatment
virus-associated
malignancies.
Pathogens,
Journal Year:
2025,
Volume and Issue:
14(5), P. 470 - 470
Published: May 13, 2025
This
research
addresses
IL-28B
gene
polymorphisms
(rs12979860
and
rs8099917)
to
determine
their
association
with
HTLV-1-related
diseases;
it
aims
compare
genotypic
frequencies
identify
predisposition
or
protection,
considering
population,
disease,
controls.
Given
HTLV-1’s
impact
on
immunity,
this
study
seeks
biomarkers
for
early
diagnosis
intervention.
A
systematic
search
met
inclusion
criteria,
such
as
open
access
bibliographic
experimental
studies
published
in
English
between
2010
2024,
genetic
factors
linked
susceptibility
pathologies.
Regarding
exclusion
organisms
other
than
humans,
unofficial
sources,
non-indexed
journals,
scientific
articles
languages
were
ruled
out.
Statistical
data
analyses
assessed
using
meta-analysis,
including
forest
plot
Q
test
of
heterogeneity
based
the
I2
statistics.
The
analyzed
indicate
associations
genotypes,
CT,
GG,
CC,
TT
rs12979890
rs8099917
various
diseases,
HCV,
arthropathy,
HAM/TSP,
cytomegalovirus
Crimean–Congo
hemorrhagic
fever
associated
HTLV-1;
however,
observed
inconsistencies,
high
heterogeneity,
deficiency
related
information
limit
consolidation
findings.
Further
is
needed
clarify
genotype
interactions
disease
HTLV-1
infections.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(6), P. 5966 - 5966
Published: March 22, 2023
Genetic
mutations
or
environmental
agents
are
major
contributors
to
leukemia
and
associated
with
genomic
instability.
R-loops
three-stranded
nucleic
acid
structures
consisting
of
an
RNA–DNA
hybrid
a
non-template
single-stranded
DNA.
These
regulate
various
cellular
processes,
including
transcription,
replication,
DSB
repair.
However,
unregulated
R-loop
formation
can
cause
DNA
damage
instability,
which
potential
drivers
cancer
leukemia.
In
this
review,
we
discuss
the
current
understanding
aberrant
how
it
influences
instability
development.
We
also
consider
possibility
as
therapeutic
targets
for
treatment.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(10), P. 5486 - 5486
Published: May 14, 2022
Human
T
cell
leukemia
virus
type
1
(HTLV-1)
was
identified
as
the
first
pathogenic
human
retrovirus
and
is
estimated
to
infect
5
10
million
individuals
worldwide.
Unlike
other
retroviruses,
there
no
effective
therapy
prevent
onset
of
most
alarming
diseases
caused
by
HTLV-1,
more
severe
cases
manifest
malignant
phenotype
adult
(ATL).
MicroRNA
(miRNA)
dysfunction
a
common
feature
leukemogenesis,
it
different
in
ATL
cases.
Therefore,
we
sought
analyze
studies
that
reported
deregulated
miRNA
expression
HTLV-1
infected
cells
patients’
samples
understand
how
this
deregulation
could
induce
malignancy.
Through
silico
analysis,
12
miRNAs
stood
out
prediction
targets,
performed
functional
annotation
genes
linked
these
appeared
have
major
biological
interaction.
A
total
90
were
enriched
14
KEGG
pathways
with
significant
values,
including
TP53,
WNT,
MAPK,
TGF-β,
Ras
signaling
pathways.
These
gene
interactions
are
discussed
further
detail
for
elucidation
they
may
act
probable
drivers
onset,
while
our
data
provide
solid
starting
points
comprehension
miRNAs’
roles
infection,
continuous
effort
oncologic
research
still
needed
improve
understanding
induced
leukemia.
Pathogens,
Journal Year:
2023,
Volume and Issue:
12(2), P. 182 - 182
Published: Jan. 24, 2023
Human
T-cell
leukemia
virus
type
1
(HTLV-1)
is
the
causal
agent
of
adult
leukemia/lymphoma
and
HTLV-1-associated
myelopathy/tropical
spastic
paraparesis.
Its
tropism
known
to
be
broad
in
cultured
cell
lines,
while
vivo
data
support
a
more
selective
transmission
toward
CD4+
T
cells
limited
targeting
other
hematopoietic
types.
An
essential
condition
for
HTLV-1
infection
cell-to-cell
contact,
which
both
virological
synapse
viral
biofilm
have
been
suggested
strongly
contribute.
As
lines
animal
models
each
present
their
own
limitations
studying
replication,
we
explored
use
an
ex
model
based
on
secondary
lymphoid
tonsillar
tissue.
HIV-1
luciferase-expressing
pseudotyped
viruses
bearing
envelope
protein
at
surface
were
first
shown
recapitulate
wide
spectrum
infectivity
various
lines.
Tonsil
fragments
next
exposed
reproducibly
infected.
Infection
by
Env-pseudotyped
was
blocked
different
anti-gp46
antibodies,
unlike
virions.
The
dose-dependent
revealed
gradual
increase
luciferase
activity,
again
sensitive
antibodies.
Overall,
these
results
suggest
that
tonsil
represents
reliable
alternative
replication
potentially
latency,
as
well
early
clonal
formation.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2023,
Volume and Issue:
13
Published: May 24, 2023
Background
Human
T-cell
leukemia
virus
type
1
(HTLV-1)
is
a
retrovirus
known
to
cause
two
major
diseases:
adult
leukemia/lymphoma
and
progressive
neuromyelopathy—tropical
spastic
paraparesis.
Many
viruses
may
be
involved
in
the
pathogenesis
of
thyroiditis;
however,
few
studies
have
focused
on
role
HTLV-1.
We
aimed
investigate
association
between
HTLV-1
biological
thyroid
dysfunction.
Methods
included
357
patients
with
positive
serology
thyroid-stimulating
hormone
assay
data
2012
2021
hospital
French
Guiana;
we
compared
prevalence
hypothyroidism
hyperthyroidism
this
group
that
an
HTLV-1-negative
control
(722
persons)
matched
for
sex
age.
Results
The
infection
was
significantly
higher
than
(11%
versus
3.2%
11.3%
2.3%,
respectively;
p
<
0.001).
Conclusion
Our
study
shows,
first
time,
dysthyroidism
large
sample,
suggesting
function
exploration
should
systematically
implemented
population
as
impact
therapeutic
management.